By documenting this variant in an Iranian family, we provide evidence that ATRIP-associated breast cancer susceptibility is not confined to European populations previously studied and may have broader global relevance, highlighting the importance of evaluating such novel risk candidate genes across diverse populations. Here, ATRIP is linked to breast carcinoma.